SDF-1alpha/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus.
SDF-1alpha/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus.
复制标题
DOI:
10.1016/j.neuropharm.2009.08.022
复制
发表时间:
2010-02
影响因子:
4.7
通讯作者:
Kirby, Lynn G.
中科院分区:
文献类型:
--
作者:
Heinisch, Silke;Kirby, Lynn G.
The serotonin (5-hydroxytryptamine; 5-HT) system has a well-characterized role in depression. Recent reports describe comorbidities of mood-immune disorders, suggesting an immunological component may contribute to the pathogenesis of depression as well. Chemokines, immune proteins which mediate leukocyte trafficking, and their receptors are widely distributed in the brain, mediate neuronal patterning, and modulate various neuropathologies. The purpose of this study was to investigate the neuroanatomical relationship and functional impact of the chemokine stromal cell-derived factor-1α/CXCL12 and its receptor, CXCR4, on the serotonin dorsal raphe nucleus (DRN) system in the rat using anatomical and electrophysiological techniques. Immunohistochemical analysis indicates that over 70% of 5-HT neurons colocalize with CXCL12 and CXCR4. At a subcellular level, CXCL12 localizes throughout the cytoplasm whereas CXCR4 concentrates to the outer membrane and processes of 5-HT neurons. CXCL12 and CXCR4 also colocalize on individual DRN cells. Furthermore, electrophysiological studies demonstrate CXCL12 depolarization of 5-HT neurons indirectly via glutamate synaptic inputs. CXCL12 also enhances the frequency of spontaneous inhibitory and excitatory postsynaptic currents (sIPSC and sEPSC). CXCL12 concentration-dependently increases evoked IPSC amplitude and decreases evoked IPSC paired-pulse ratio selectively in 5-HT neurons, effects blocked by the CXCR4 antagonist AMD3100. These data indicate presynaptic enhancement of GABA and glutamate release at 5-HT DRN neurons by CXCL12. Immunohistochemical analysis further shows CXCR4 localization to DRN GABA neurons, providing an anatomical basis for CXCL12 effects on GABA release. Thus, CXCL12 indirectly modulates 5-HT neurotransmission via GABA and glutamate synaptic afferents. Future therapies targeting CXCL12 and other chemokines may treat serotonin related mood disorders, particularly depression experienced by immune-compromised individuals.
登录
查看更多内容
影响因子:
4.8
作者:
Callewaere, Celine;Fernette, Brigitte;Rostene, William
通讯作者:
Rostene, William
DOI:
10.1073/pnas.0602620103
发表时间:
2006-05-23
影响因子:
11.1
作者:
Callewaere, Celine;Banisadr, Ghazal;Parsadaniantz, Stephane Melik
通讯作者:
Parsadaniantz, Stephane Melik
DOI:
10.1073/pnas.95.3.1283
发表时间:
1998-02-03
影响因子:
11.1
作者:
Goda, Y;Stevens, CF
通讯作者:
Stevens, CF
影响因子:
4.7
作者:
Bajetto, A;Bonavia, R;Schettini, G
通讯作者:
Schettini, G
DOI:
10.1196/annals.1296.005
发表时间:
2004-01-01
期刊:
STRESS: CURRENT NEUROENDOCRINE AND GENETIC APPROACHES
影响因子:
--
作者:
Abrams, JK;Johnson, PL;Lowry, CA
通讯作者:
Lowry, CA